Oncotelic Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Oncotelic Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Oncotelic Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 407M shares, a 2.29% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 407M +9.13M +2.29% Sep 30, 2024 10-Q 2024-11-19
Q2 2024 407M +9.76M +2.46% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 400M +6.81M +1.73% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 399M +7.34M +1.87% Dec 31, 2023 10-Q 2024-11-19
Q3 2023 398M +7.96M +2.04% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 398M +11.5M +2.98% Jun 30, 2023 10-Q 2023-08-18
Q1 2023 393M +14.2M +3.76% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 392M +16.6M +4.41% Dec 31, 2022 10-K 2024-04-12
Q3 2022 390M +17.6M +4.73% Sep 30, 2022 10-Q 2022-11-18
Q2 2022 386M +15.9M +4.31% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 379M +9.18M +2.49% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 375M +285M +314% Dec 31, 2021 10-K/A 2023-04-20
Q3 2021 373M +283M +316% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 370M +281M +318% Jun 30, 2021 10-Q 2021-08-20
Q1 2021 369M +281M +320% Mar 31, 2021 10-Q 2021-05-24
Q4 2020 90.6M +6.53M +7.77% Dec 31, 2020 10-K 2022-04-15
Q3 2020 89.6M +6.13M +7.35% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 88.6M +5.13M +6.15% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 88M +46.6M +113% Mar 31, 2020 10-Q 2020-06-29
Q4 2019 84.1M +77.2M +1128% Dec 31, 2019 10-K 2021-04-15
Q3 2019 83.5M +42M +102% Sep 30, 2019 10-Q 2019-11-19
Q2 2019 83.5M +42M +102% Jun 30, 2019 10-Q 2019-08-19
Q1 2019 41.4M +14.9M +56% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 6.84M -19.7M -74.2% Dec 31, 2018 10-K 2020-05-14
Q3 2018 41.4M +14.9M +56% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 41.4M +14.9M +56% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 26.5M 0 0% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 26.5M 0 0% Dec 31, 2017 10-K 2019-04-10
Q3 2017 26.5M 0 0% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 26.5M 0 0% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 26.5M 0 0% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 26.5M 0 0% Dec 31, 2016 10-K 2018-04-17
Q3 2016 26.5M 0 0% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 26.5M 0 0% Jun 30, 2016 10-Q 2016-08-02
Q1 2016 26.5M 0 0% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 26.5M +5.84M +28.2% Dec 31, 2015 10-K 2017-03-30
Q3 2015 26.5M +5.84M +28.2% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 26.5M +5.84M +28.2% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 26.5M +11.3M +73.6% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 20.7M +15.1M +271% Dec 31, 2014 10-K 2016-03-25
Q3 2014 20.7M +17.7M +590% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 20.7M +18.4M +810% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 15.3M +13.2M +637% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 5.59M +3.84M +220% Dec 31, 2013 10-K 2015-03-30
Q3 2013 3M -16.8M -84.8% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 2.27M -15.3M -87% Jun 30, 2013 10-Q/A 2013-10-18
Q1 2013 2.08M -14.1M -87.2% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 1.75M +481K +38% Dec 31, 2012 10-K 2014-03-20
Q3 2012 19.8M +4.99M +33.8% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 17.5M +5.86M +50.2% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 16.2M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 1.27M -4.24M -77% Dec 31, 2011 10-K 2013-03-15
Q3 2011 14.8M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 11.7M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 5.5M Dec 31, 2010 10-K 2012-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.